Search

Search Constraints

You searched for: Author/Creator Panda, Prashanta Kumar

Search Results

1. Abrus agglutinin is a potent anti‐proliferative and anti‐angiogenic agent in human breast cancer. Issue 2 (30th March 2016)

3. Abrus Agglutinin, a type II ribosome inactivating protein inhibits Akt/PH domain to induce endoplasmic reticulum stress mediated autophagy‐dependent cell death. Issue 2 (31st May 2016)

4. Autophagy regulates cisplatin‐induced stemness and chemoresistance via the upregulation of CD44, ABCB1 and ADAM17 in oral squamous cell carcinoma. (23rd November 2017)

6. Clinical relevance of autophagic therapy in cancer: Investigating the current trends, challenges, and future prospects. (3rd July 2016)

7. Corrigendum to "In vitro and in vivo antitumor effects of Peanut agglutinin through induction of apoptotic and autophagic cell death" [Food Chem. Toxicol. 2014 64 369-77]. (April 2022)

8. Deacetylation of LAMP1 drives lipophagy‐dependent generation of free fatty acids by Abrus agglutinin to promote senescence in prostate cancer. Issue 3 (23rd September 2019)